Evidence map›Paper›PMID 38485275›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2024

[

Joanna C Porter, Balaji Ganeshan, Thida Win, Francesco Fraioli, Saif Khan, Manuel Rodriguez-Justo, Raymond Endozo, Robert I Shortman, Luke R Hoy, Toby M Maher and 1 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Joanna C PorterCITR, UCL Respiratory, University College London, London, United Kingdom; joanna.porter@ucl.ac.uk.
Balaji GaneshanInstitute of Nuclear Medicine, University College London and University College London Hospital, London, United Kingdom.
Thida WinLister Hospital, North East Herts Trust, Stevenage, United Kingdom.
Francesco FraioliInstitute of Nuclear Medicine, University College London and University College London Hospital, London, United Kingdom.
Saif KhanResearch Department of Pathology, University College London, and Department of Histopathology, University College London Hospital, London, United Kingdom; and.
Manuel Rodriguez-JustoResearch Department of Pathology, University College London, and Department of Histopathology, University College London Hospital, London, United Kingdom; and.
Raymond EndozoInstitute of Nuclear Medicine, University College London and University College London Hospital, London, United Kingdom.
Robert I ShortmanInstitute of Nuclear Medicine, University College London and University College London Hospital, London, United Kingdom.
Luke R HoyInstitute of Nuclear Medicine, University College London and University College London Hospital, London, United Kingdom.
Toby M MaherKeck School of Medicine, University of Southern California, Los Angeles, California.
Ashley M GrovesInstitute of Nuclear Medicine, University College London and University College London Hospital, London, United Kingdom.
University College Hospital · GBUniversity College London · GBEast and North Hertfordshire NHS Trust · GBUniversity of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of [

Indexed as

Lung Diseases, InterstitialPositron Emission Tomography Computed TomographyBiomarkersBiopsyFibrosisFluorodeoxyglucose F18Glucose Transporter Type 1HumansLungNeovascularization, PathologicPrognosisBiomarkersFluorodeoxyglucose F18Glucose Transporter Type 1[18F]FDG PET/CTangiogenesisfibrosisILDmicrovessel

Identifiers

PMID38485275
PMCPMC10995524
OpenAlexW4392818841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.